Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication
Artículo científico (JournalArticle)
Health-related quality of life and mortality in the 'Seguimiento Universidad de Navarra' prospective cohort study
Objective: To study the association between health-related quality of life (HRQoL) and all-cause mortality in a
healthy middle-aged Mediterranean cohort.
Methods: We included 15,390 participants –mean age 42.8 years at first HRQoL ascertainment, all university
graduates–. HRQoL was assessed with the self-administered Medical Outcomes Study Short Form-36 (SF-36)
twice, with a 4-year gap. We used multivariable-adjusted Cox regression models to address the relation between
self-reported health and Physical or Mental Component Summary (PCS-36 or MCS-36) and mortality, and their
interaction with prior comorbidities or adherence to the Mediterranean diet (MedDiet).
Results: Over 8.7 years of median follow-up time, 266 deaths were identified. Hazard ratio (HR) for the excellent
vs. poor/fair category in self-reported health was 0.30 (95 % confidence interval (CI), 0.16–0.57) in the model
with repeated measurements of HRQoL. Both the PCS-36 (HRquartile4(Q4)vs.Q1 0.57 [95%CI, 0.36–0.90], ptrend <
0.001; HRper+10points: 0.64 [95%CI, 0.54–0.75]) and the MCS-36 (HRQ4vs.Q1 0.67 [95%CI, 0.46–0.97], ptrend =
0.025; HRper+10points: 0.86 [95%CI, 0.74–0.99]) were inversely associated with mortality in the model with
repeated measurements of HRQoL. Previous comorbidities or adherence to the MedDiet did not modify these
associations.
Conclusions: Self-reported HRQoL –assessed as self-reported health, PCS-36 and MCS-36– obtained with the
Spanish version of the SF-36 were inversely associated with mortality risk, regardless of the presence of previous
comorbidities or adherence to the MedDiet., This project was made possible by funding from the Spanish Government-Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, PI18/00631, PI20/00564 and G03/140), from the Government of Navarra (27/2011, 45/2011, 122/2014), from the National Plan on Drugs (2020/021) as well as from the University of Navarra.
Project:
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI10-02658
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI10-02293
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI13-00615
,
MINECO PI14-01668
,
ISCIII PI14-01798
,
ISCIII PI14-01764
,
ISCIII PI17-01795
,
Gobierno de Navarra PI18-00631
,
Gobierno de Navarra PI20-00564
,
Gobierno de Navarra 027-2011
,
45-2011
,
122-2014
View at: https://hdl.handle.net/2454/46611